Niggi Iberg
Hoffmann-La Roche
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Niggi Iberg.
Biochemical and Biophysical Research Communications | 2002
Frédérique Paulhe; Bertrand Perret; Hugues Chap; Niggi Iberg; Olivier Morand
The involvement of phosphoinositide 3-kinase C2α in vascular smooth muscle cell migration was investigated. Products of phosphoinositide 3-kinase, phosphatidylinositol-3-phosphate, and phosphatidylinositol-3,4-bis-phosphate were increased upon smooth muscle cell migration but their synthesis was affected only partially by phosphoinositide 3-kinase inhibitors, wortmannin and LY-294002. Using specific antibody, we showed that the wortmannin/LY-294002 poorly sensitive phosphoinositide 3-kinase C2α is expressed in smooth muscle cells. Measurement of phosphoinositide 3-kinase C2α activity in vitro, after immunoprecipitation, clearly demonstrated its activation upon smooth muscle cell migration. Moreover, for the first time, phosphoinositide 3-kinase C2α was found to be differentially regulated by α v β 3 and α v β 5 integrin engagement. Finally, we have identified two new potential phosphoinositide 3-kinase C2α-binding proteins, p70 and p110, which both may be tyrosine phosphorylated. Thus, phosphoinositide 3-kinase C2α might represent a new regulatory pathway of cell migration downstream of integrin engagement.
Bioorganic & Medicinal Chemistry Letters | 1994
Hans Peter Wessel; Thomas B. Tschopp; Markus Hosang; Niggi Iberg
Abstract Investigation of the smooth muscle cell antiproliferative activities of Trestatin A sulfate substructures showed that a sulfated pentasaccharide is required to maintain a heparin-like effect. The modification of one glycosidic bond led to a synthetically readily available tetrasaccharide, namely sulfated β-maltosyl trehalose12, with similar antiproliferative but devoid of anticoagulant acitivity.
Bioorganic & Medicinal Chemistry Letters | 1995
Hans Peter Wessel; Eric Vieira; Michel Trumtel; Thomas B. Tschopp; Niggi Iberg
Abstract The sulfated tetrasaccharide β-maltosyl-(1→4)-α,α-trehalose 2 with high antiproliferative activity on smooth muscle cells was modified in the maltosyl moiety by linking eight different disaccharides equatorially to trehalose; the biological activity varied strongly between different structures.
Bioorganic & Medicinal Chemistry Letters | 1996
Hans Peter Wessel; Niggi Iberg; Michel Trumtel; Marie-Claude Viaud
Abstract Selectively deoxygenated analogues of highly (ca. 80 %) sulfated β-maltosyl-(1→4)-α,α-trehalose were investigated to map the importance of the individual sulfates for biological activity. Single deoxygenations led to activity losses up to 30 %; the essential sulfates are located on the outer glucopyranosyl rings of the molecule.
Bioorganic & Medicinal Chemistry Letters | 1996
Hans Peter Wessel; Niggi Iberg
Abstract Heparan sulfate model oligosaccharides were devised with the simplyfying assumptions that i) carboxyl-reduction and subsequent sulfation of heparan sulfate does not decrease the SMC antiproliferative activity, and ii) N -Sulfates in glucosamines can be replaced by O -sulfates. These heparan sulfate model oligosaccharides are more active than analogous heparin fractions.
Archive | 1995
Alexander Chucholowski; Jürgen Fingerle; Niggi Iberg; Hans Peter Märki; Rita Müller; Michael Pech; Marianne Rouge; Gerard Schmid; Thomas B. Tschopp; Hans Peter Wessel
Journal of Biological Chemistry | 2001
Frédérique Paulhe; Claire Racaud-Sultan; Ashraf Ragab; Corinne Albiges-Rizo; Hugues Chap; Niggi Iberg; Olivier Morand; Bertrand Perret
Journal of Biological Chemistry | 2001
Frédérique Paulhe; Ashraf Ragab; Corinne Albiges-Rizo; Hugues Chap; Niggi Iberg; Olivier Morand; Bertrand Perret
Archive | 1996
Alexander Chucholowski; Jürgen Fingerle; Niggi Iberg; Hans Peter Märki; Rita Müller; Michael Pech; Marianne Rouge; Gerard Schmid; Thomas B. Tschopp; Hans Peter Wessel
Archive | 1992
Markus Hosang; Niggi Iberg; Thomas B. Tschopp; Hans Peter Wessel